Bronchial Hyperresponsiveness

Allergy and Allergic Diseases, Second Edition

Volumn 1, Issue , 2009, Pages 783-793

  Joos, Guy F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Adenosine monophosphate (AMP); BHR and antiasthma drugs; BHR in asthma relation to airway inflammation and airway remodeling; Bronchial hyperresponsiveness; Bronchial provocation testing and airway response measurement; Bronchial responsiveness measures; Bronchial responsiveness measuring methods; Direct and indirect bronchial challenges; Steroid induced improvement in direct bronchial responsiveness

Indexed keywords

EID: 84889314658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300918.ch35     Document Type: Chapter

References (83)

1. Alexander, H.L. & Paddock, R. (1921) Bronchial asthma: response to pilocarpine and epineprine. Arch Intern Med 27, 184-91.
2. American Thoracic Society (2000) Guidelines for methacholine and exercise challenge testing: 1999. Am J Respir Crit Care Med 161, 309-29.
3. Anderson, S.D. & Brannan, J.D. (2003) Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol 24, 27-54.
4. Anderson, S.D. & Daviskas, E. (2000) The mechanism of exerciseinduced asthma is ... J Allergy Clin Immunol 106, 453-9.
5. Anderson, S.D., Brannan, J., Spring, J. et al. (1997) A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 156, 758-65.
6. Beaupré, A. & Malo, J.L. (1979) Comparison of histamine bronchial challenges with the Wright nebulizer and the dosimeter. Clin Allergy 9, 575-83.
7. Boulet, L.P. (2003) Asymptomatic airway hyperresponsiveness. A curiosity or an opportunity to prevent asthma? Am J Respir Crit Care Med 167, 371-8.
8. Bousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M. & Vignola, A.M. (2000) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161, 1720-45.
9. Brannan, J.D., Anderson, S.D., Perry, C.P., Freed-Martens, R., Lassig, A.R. & Charlton, B. (2005) The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 6, 144.
10. British Thoracic Society (2003) British Thoracic Society guidelines on respiratory aspects of fitness for diving. Thorax 58, 3-13.
11. Brusasco, V., Crimi, E. & Pellegrino, R. (1998) Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 53, 992-8.
12. Chai, H., Farr, R.S., Froehlich, L.A. et al. (1975) Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 56, 323-7.
13. Cockcroft, D.W. (2001) How best to measure airway responsiveness. Am J Respir Crit Care Med 163, 1514-15.
14. Cockcroft, D.W., Killian, D.N., Mellon, J.J. & Hargreave, F.E. (1977) Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 7, 235-43.
15. Curry, J.J. (1947) Comparative action of acetyl-beta-methyl choline and histamine on the respiratory tract in normals, patients with hay fever, and subjects with bronchial asthma. J Clin Invest 26, 430-8.
16. De Meer, G., Heederik, D. & Postma, D.S. (2002) Bronchial responsiveness to adenosine 5′-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1). Am J Respir Crit Care Med 165, 327-31.
17. De Vries, K., Goei, J., Booy-Noord, H. & Orie, N. (1962) Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy Appl Immunol 20, 93-101.
18. Djukanovic, R., Wilson, J.W., Britten, K.M. et al. (1992) Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145, 669-74.
19. Djukanovic, R., Sterk, P.J., Fahy, J.V. & Hargreave, F.E. (2002) Standardised methodology of sputum induction and processing. Eur Respir J Suppl 37, 1s-2s.
20. Eiser, N.M., Kerrebijn, K. & Quanjer, P.H. (1983) Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents. Clin Respir Physiol 19, 495-514.
21. Fish, J.E. & Kelly, J.F. (1979) Measurements of responsiveness in bronchoprovocation testing. J Allergy Clin Immunol 64, 592-6.
22. Gibson, P.G. (2000) Monitoring the patient with asthma: an evidencebased approach. J Allergy Clin Immunol 106, 17-26.
23. Global Initiative for Asthma (2006) Global strategy for asthma management and prevention. Available at www.ginasthma.org.
24. Grashoff, W.F., Sont, J.K., Sterk, P.J. et al. (1997) Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol 151, 1785-90.
25. Green, R.H., Brightling, C.E., McKenna, S. et al. (2002) Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360, 1715-21.
26. Gronke, L., Kanniess, F., Holz, O., Jorres, R.A. & Magnussen, H. (2002) The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 32, 57-63.
27. Herxheimer, H. (1951) Bronchial obstruction induced by allergens, histamine and acetyl-beta-methylcholinechloride. Int Arch Allergy Appl Immunol 2, 27-39.
28. Hofstra, W.B., Neijens, H.J., Duiverman, E.J. et al. (2000) Dose- responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 29, 415-23.
29. Holgate, S.T. (2002a) Adenosine provocation: a new test for allergic type airway inflammation. Am J Respir Crit Care Med 165, 317-18.
30. Holgate, S. T. (2002b) Adenosine: a key effector molecule of asthma or just another mediator? Am J Physiol 282, L167-L168.
31. Jayaram, L., Parameswaran, K., Sears, M.R. & Hargreave, F.E. (2000) Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 16, 150-8.
32. Joos, G.F. (2001) Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma? Eur Respir J 18, 439-41.
33. Joos, G. & O'Connor, B. (2003) ERS Task Force: indirect airway challenges. Eur Respir J 21, 1050-68.
34. Joos, G. & Pauwels, R.A. (1996) Adenosine receptors involved in the bronchoconstrictor effect of adenosine. Drug Dev Res 39, 330-2.
35. Joos, G.F. & Pauwels, R.A. (2000) Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases? Trends Pharmacol Sci 21, 131-3.
36. Joos, G.F. & Pauwels, R.A. (2001) Tachykinin receptor antagonists: potential in airways diseases. Curr Opin Pharmacol 1, 235-41.
37. Joos, G.F., De Swert, K.O. & Pauwels, R.A. (2001) Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur J Pharmacol 429, 239-50.
38. Joos, G.F., Vincken, W., Louis, R.E. et al. (2004) Dual NK1/NK2 tachykinin receptor antagonist DNK333 inhibits neurokinin A- induced bronchoconstriction in asthma patients. Eur Respir J 23, 76-81.
39. Juniper, E.F., Frith, P.A. & Hargreave, F.E. (1981) Airway responsiveness to histamine and methacholine - relationship to minimum treatment to control symptoms of asthma. Thorax 36, 575-9.
40. Kharitonov, S.A. & Barnes, P.J. (2000) Clinical aspects of exhaled nitric oxide. Eur Respir J 16, 781-92.
41. Lötvall, J., Inman, M. & O'Byrne, P. (2000) Measurement of airway hyperresponsiveness: new considerations. Thorax 53, 419-24.
42. Louis, R., Sele, J., Henket, M. et al. (2002a) Sputum eosinophil count in a large population of patients with mild to moderate steroidnaive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 57, 907-12.
43. Louis, R.E., Cataldo, D., Buckley, M.G. et al. (2002b) Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. Eur Respir J 20, 325-31.
44. Mullen, J.B., Wiggs, B.R., Wright, J.L., Hogg, J.C. & Pare, P.D. (1986) Nonspecific airway reactivity in cigarette smokers. Relationship to airway pathology and baseline lung function. Am Rev Respir Dis 133, 120-5.
45. O'Connor, B.J., Towse, L.J. & Barnes, P.J. (1996) Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 154, 876-80.
46. Orehek, J., Nicoli, M.M., Delpierre, S. & Beaupre, A. (1981) Influence of the previous deep inspiration on the spirometric measurement of provoked bronchoconstriction in asthma. Am Rev Respir Dis 123, 269-72.
47. Pauwels, R., Joos, G. & Van der Straeten, M. (1988) Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 18, 317-21.
48. Pauwels, R.A., Joos, G.F. & Kips, J.C. (1995) Leukotrienes as therapeutic target in asthma. Allergy 50, 615-22.
49. Polosa, R. (2002) Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 20, 488-96.
50. Polosa, R., Rorke, S. & Holgate, S.T. (2002) Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax 57, 649-54.
51. Prosperini, G., Rajakulasingam, K., Cacciola, R.R. et al. (2002) Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy Clin Immunol 110, 855-61.
52. Rasmussen, F., Lambrechtsen, J., Siersted, H.C., Hansen, H.S. & Hansen, N.C. (1999) Asymptomatic bronchial hyperresponsiveness to exercise in childhood and the development of asthma related symptoms in young adulthood: the Odense Schoolchild Study. Thorax 54, 587-9.
53. Reynolds, C.J., Togias, A. & Proud, D. (2002) Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone. Clin Exp Allergy 32, 1174-9.
54. Rorke, S., Jennison, S., Jeffs, J.A., Sampson, A.P., Arshad, H. & Holgate, S.T. (2002) Role of cysteinyl leukotrienes in adenosine 5′- monophosphate induced bronchoconstriction in asthma. Thorax 57, 323-7.
55. Rosi, E. & Scano, G, (2000) Association of sputum parameters with clinical and functional measurements in asthma Thorax 55, 235-8.
56. Rosi, E., Ronchi, M.C., Grazzini, M., Duranti, R. & Scano, G. (1999) Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 103, 232-7.
57. Ryan, G., Dolovich, M.B., Obminski, G. et al. (1981) Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol 67, 156-61.
58. Salome, C.M., Peat, J.K., Britton, W.J. & Woolcock, A.J. (1987). Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy 17, 271-81.
59. Schelfhout, V., Louis, R., Lenz, W., Heyrman, R., Pauwels, R. & Joos, G. (2006) The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulm Pharmacol Ther 19, 413-18.
60. Smith, A.D., Cowan, J.O., Brassett, K.P., Herbison, G.P. & Taylor, D.R. (2005) Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352, 2163-73.
61. Sont, J.K., Han, J., van Krieken, J.M. et al. (1996) Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51, 496-502.
62. Sont, J.K., Willems, L.N., Bel, E.H., van Krieken, J.H., Van den broucke, J.P. & Sterk, P.J. (1999) Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159, 1043-51.
63. Sterk, P.J., Daniel, E.E., Zamel, N. & Hargreave, F.E. (1985) Limited maximal airway narrowing in nonasthmatic subjects. Role of neural control and prostaglandin release. Am Rev Respir Dis 132, 865-70.
64. Sterk, P.J., Fabbri, L.M., Quanjer, Ph.H. et al. (1993) Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests. Eur Respir J 6 (suppl. 16), 53-83.
65. Tashkin, D.P., Altose, M.D., Bleecker, E.R. et al. (1992) The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 145, 301-10.
66. Tiffeneau, R. & Beauvallet, M. (1945) Epreuve de bronchoconstriction et de bronchodilation par aerosols. Bull Acad Med 129, 165-8.
67. van den Berge, M., Meijer, R.J., Kerstjens, H.A. et al. (2001a) Pc(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than pc(20) methacholine. Am J Respir Crit Care Med 163, 1546-50.
68. van den Berge M., Kerstjens, H.A., Meijer, R.J. et al. (2001b) Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 164, 1127-32.
69. van den Berge M., Kerstjens, H.A. & Postma, D.S. (2002) Provocation with adenosine 5′-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease. Clin Exp Allergy 32, 824-30.
70. van den Toorn, L.M., Prins, J.B., Overbeek, S.E., Hoogsteden, H.C. & de Jongste, J.C. (2000) Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 162, 953-7.
71. van den Toorn, L.M., Overbeek, S.E., de Jongste, J.C., Leman, K., Hoogsteden, H.C. & Prins, J.B. (2001) Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 164, 2107-13.
72. Van Rensen, E.L., Hiemstra, P.S., Rabe, K.F. & Sterk, P.J. (2002) Assessment of microvascular leakage via sputum induction: the role of substance P and neurokinin A in patients with asthma. Am J Respir Crit Care Med 165, 1275-9.
73. Van Schoor, J., Joos, G.F., Kips, J.C., Drajesk, J.F., Carpentier, P.J. & Pauwels, R.A. (1997) The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 155, 875-80.
74. Van Schoor, J., Joos, G.F., Chasson, B.L., Brouard, R.J. & Pauwels, R.A. (1998) The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. Eur Respir J 12, 17-23.
75. Van Schoor, J., Joos, G.F. & Pauwels, R.A. (2000) Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 16, 514-33.
76. Van Schoor, J., Joos, G. & Pauwels, R.A. (2002) Effect of inhaled fluticasone propionate on bronchial responsiveness to neurokinin A in asthma. Eur Respir J 18, 997-1002.
77. Van Schoor, J., Pauwels, R. & Joos, G. (2005) Indirect bronchial hyperresponsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 35, 250-61.
78. van Velzen, E., van den Bos, J.W., Benckhuijsen, J.A., van Essel, T., de Bruijn, R. & Aalbers, R. (1996) Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 51, 582-4.
79. Vizi, E., Huszar, E., Csoma, Z. et al. (2002) Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol 109, 446-8.
80. Ward, C., Pais, M., Bish, R. et al. (2002) Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57, 309-16.
81. Weiss, S., Robb, G.P. & Ellis, L.B. (1932) The systemic effects of histamine in man with special reference to the cardiovascular system. Arch Intern Med 49, 360-9.
82. Woolcock, A.J., Yan, K. & Salome, C.M. (1988) Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy 18, 165-76.
83. Woolcock, A.J., Anderson, S.D., Peat, J.K. et al. (1991) Characteristics of bronchial hyperresponsiveness in chronic obstructive pulmonary disease and in asthma. Am Rev Respir Dis 143, 1438-43.